跳至主要内容
临床试验/NCT07412249
NCT07412249招募中不适用

Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis (RICSICAS): A Prospective, Randomized Controlled, Blind Endpoint, Single-Center Study

General Hospital of Shenyang Military Region1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2026年3月4日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
300
试验地点
1
主要终点
time to the first occurrence of any component of the composite endpoint within 12 months post-randomization

研究概览

简要总结

Remote ischemic conditioning (RIC) has emerged as a promising non-invasive strategy to protect the brain, with evidence suggesting its benefit in patients with carotid artery stenting (CAS). However, the long-term benefit and safety of chronic RIC in this population remain unknown. This trial aims to evaluate whether chronic RIC reduces the incidence of major vascular events and improves clinical outcomes in high-risk patients with carotid artery stenosis who received CAS.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 40 years old;
  • Patients with symptomatic moderate to severe stenosis of the internal carotid artery;
  • History of ipsilateral cerebral ischemic symptoms within the past 180 days;
  • Planned for carotid artery stent;
  • Essen Score ≥ 3;
  • Modified Rankin Scale score of 0 or 1;
  • Signed informed consent.

排除标准

  • Uncontrolled severe hypertension (systolic blood pressure > 180 mmHg or diastolic blood pressure > 110 mmHg despite medication)
  • Subclavian artery stenosis ≥ 50% or presence of subclavian steal syndrome
  • Severe hematological disorders or significant coagulation abnormalities
  • Contraindications to remote ischemic conditioning, such as severe soft tissue injury, fracture, or vascular injury in the upper limbs, or peripheral vascular disease in the distal upper limbs
  • Severe comorbid conditions with a life expectancy of less than 1 year
  • Participation in another clinical trial within the past 3 months or ongoing participation
  • Any other circumstances deemed by the investigator as unsuitable for participation in this clinical study.

研究组 & 干预措施

RIC group

Experimental

The RIC protocol involves bilateral upper-arm cuff inflation to 200 mmHg (5-min inflation/5-min deflation, 5 cycles) performed 1-2 times daily, starting 3 days before CAS and continuing for 12 months post-procedure.

干预措施: Remote ischemic conditioning (Device)

Control group

No Intervention

no RIC treatment

结局指标

主要结局

time to the first occurrence of any component of the composite endpoint within 12 months post-randomization

时间窗: 1 year

the composite endpoint includes ischemic stroke, hemorrhagic stroke, myocardial infarction \[including coronary revascularization\], TIA, or vascular death

次要结局

  • occurrence of contrast staining on brain computerized tomography(1 hours and 24 hours after carotid artery stenting)
  • occurrence of cerebral hyperperfusion syndrome(24 hours after carotid artery stenting)
  • occurence of new infarct on brain magnetic resonance imaging(24 hours after carotid artery stenting)
  • change in collateral circulation status (assessed by Computed Tomography Angiography or Digital Subtraction Angiograph) from baseline to 12 months(1 year)
  • all-cause mortality(1 year)
  • composite of periprocedural death, stroke, or myocardial infarction(30±3 days)
  • occurence of non-fatal stroke and TIA(1 year)
  • occurence of nonfatal myocardial infarction(1 year)
  • numbers of new silent cerebral infarcts on Magnetic Resonance Imaging(1 year)
  • occurence of ipsilateral (to the stented artery) nonfatal stroke and transient ischemic attack(1 year)
  • degree of in-stent restenosis (≥50%) on Computed Tomography Angiography(1 year)
  • changes in modified Rankin Scale (mRS) scores over time(1 year)

研究者

发起方
General Hospital of Shenyang Military Region
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hui-Sheng Chen

Director

General Hospital of Shenyang Military Region

研究点 (1)

Loading locations...

相似试验